System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Livenow

Terminal Asset View

stockNASDAQ

KZIA

$7.49-6.49%

Kazia Therapeutics Ltd

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

12Overripe

Live Analysis Active

Company Mission

Kazia Therapeutics creates experimental medicines designed to fight cancer, specifically focusing on treatments for brain tumors like glioblastoma. The company works with doctors and hospitals to test these drugs in clinical trials with real patients. Kazia makes money by partnering with larger pharmaceutical companies for research funding and hopes to eventually earn revenue from selling approved drugs to patients and healthcare providers.

KZI

Industry Context

Kazia operates in the biotechnology industry, which focuses on developing new medical treatments through scientific research. This industry is known for high risk and high reward, as companies spend years and millions of dollars testing experimental drugs that might not work, but successful drugs can be extremely valuable.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

56Matrix

Market Momentum

49.2— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-6.49%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing KZIA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:37 AM UTC

As-of 03-15-2026 07:21 UTC

Develops cancer drugs and makes money by selling them to hospitals and pharmacies after successful clinical trials.

Stock price has been declining for several months, suggesting investors are cautious about the company's drug development progress showing showing.

Biotech sector faces high risk as many experimental drugs fail in trials, making investors watch for positive clinical results at key price levels, suggesting price levels.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...